Neuronetics falls after dour 2023 revenue forecast

Neuronetics

07/03/2023 15:48

**  Shares of medtech firm Neuronetics Inc  STIM.O  fall
16.1% to $4.37 
    ** Co expects full-year 2023 revenue to be between $66 mln
and $72 mln, below analysts' average estimate of $73.51 mln
-Refinitiv  
    ** STIM also reports full-year 2022 revenues of $18.2 mln,
above analysts' estimates of $16.82 mln -Refinitiv  
    ** Co beats revenue estimates for 5 quarters in a row
-Refinitiv 
    ** Including session's move, stock up ~55% over the past 12
months

 (Reporting by Mariam Sunny in Bengaluru)
 ((Mariam.ESunny@thomsonreuters.com;))